Corcept Therapeutics reported $95.43M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Ani Pharmaceuticals ANIP:US $ 24.26M 0.81M
Ardelyx ARDX:US $ 86.74M 2.68M
Aurora Cannabis Inc ACB:CN 470.24M 85.85M
Biodelivery Sciences International BDSI:US 119.85M 3.42M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Bristol Myers Squibb BMY:US $ 11024M 42M
Canopy Growth Corp WEED:CN C$ 192.56M 525.51M
Corcept Therapeutics CORT:US $ 95.43M 43.05M
Depomed DEPO:US $ 54.43M 6.6M
Eleven Biotherapeutics EBIO:US $ 151.04M 41.07M
Eli Lilly And LLY:US $ 3220M 217.6M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Knight Therapeutics Inc GUD:CN C$ 2.3M 4.59M
Lannett LCI:US $ 93.29M 12M
Lexicon Pharmaceuticals LXRX:US $ 118.5M 20.85M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Novartis NVS:US $ 5117M 1316M
Novartis NOVN:VX SF 5117M 1316M
Omeros OMER:US $ 12.7M 3.67M
Pacira Pharmaceuticals PCRX:US $ 105.77M 39.08M
Supernus Pharmaceuticals SUPN:US $ 223.77M 31.87M
Tg Therapeutics TGTX:US $ 456.22M 15.3M
Ziopharm Oncology ZIOP:US $ 76.75M 23.31M